These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Peroperative disclosure of a case of malignant hyperthermia. Elements of suspicion of the diagnosis, in vitro study of the sensitivity of muscle fibers]. Brasdefer D, Cantineau D, Tassin M, Krivosic-Horber R, Scherpereel P. Cah Anesthesiol; 1988; 36(2):149-51. PubMed ID: 3365590 [No Abstract] [Full Text] [Related]
4. In vitro contracture tests for susceptibility to malignant hyperthermia. Rosenberg H, Reed S. Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945 [No Abstract] [Full Text] [Related]
5. [Current data on the screening of malignant hyperthermia during anesthesia]. Krivosic-Horber R, Adnet P. Chirurgie; 1983 Apr; 119(1-2):55-8. PubMed ID: 7995103 [Abstract] [Full Text] [Related]
16. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. Schuster F, Metterlein T, Negele S, Kranke P, Muellenbach RM, Schwemmer U, Roewer N, Anetseder M. Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904 [Abstract] [Full Text] [Related]
17. Malignant hyperthermia in China. Xu ZH, Luo AL, Guo XY, Ren HZ, Wang YL, Zhang X, Huang YG, Ye TH. Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816 [Abstract] [Full Text] [Related]
18. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests. Ording H, Skovgaard LT. Acta Anaesthesiol Scand; 1987 Jul; 31(5):458-61. PubMed ID: 3630590 [Abstract] [Full Text] [Related]